BioNTech SE (BNTX) Net Margin (2018 - 2025)
BioNTech SE (BNTX) reported Net Margin of 16.51% for Q4 2025, down 4532.0% on a YoY basis from 0.37% in Q4 2024, and down 421.06% sequentially from 5.14% in Q3 2025.
BioNTech SE (BNTX) Net Margin (2018 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 8 years of Net Margin data on file, last reported at 16.51% in Q4 2025.
- For the quarter ending Q4 2025, Net Margin fell 4532.0% year-over-year to 16.51%; the trailing twelve-month figure through Dec 2025 stood at 31.84% (down 679.0% YoY), and the FY2025 full-year result was 33.64%, down 856.0% from the prior year.
- Net Margin fell to 16.51% in Q4 2025, from 5.14% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 105.28% in Q1 2021 to a low of 624.55% in Q2 2024.
- A 5-year average of 36.84% and a median of 30.84% in 2023 frame the typical range for Net Margin.
- Across the five-year window, Net Margin plunged 47086 bps in 2023 and soared 46397 bps in 2025, its largest moves.
- Tracing BNTX's Net Margin over 5 years: stood at 0.0% in 2021, then soared by 166085745 bps to 95.05% in 2022, then tumbled by 38 bps to 58.72% in 2023, then slumped by 51 bps to 28.82% in 2024, then plunged by 157 bps to 16.51% in 2025.
- Business Quant data shows BNTX's Net Margin at 16.51% in Q4 2025, 5.14% in Q3 2025, and 160.58% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | -16.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.51% |
| Sep 30, 2025 | 5.14% |
| Jun 30, 2025 | -160.58% |
| Mar 31, 2025 | -259.85% |
| Dec 31, 2024 | 28.82% |
| Sep 30, 2024 | 9.58% |
| Jun 30, 2024 | -624.55% |
| Mar 31, 2024 | -185.77% |
| Dec 31, 2023 | 58.72% |
| Sep 30, 2023 | 32.86% |
| Jun 30, 2023 | -378.06% |
| Mar 31, 2023 | 71.51% |
| Dec 31, 2022 | 95.05% |
| Sep 30, 2022 | 89.66% |
| Jun 30, 2022 | 92.81% |
| Mar 31, 2022 | 99.42% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 100.60% |
| Jun 30, 2021 | 99.06% |
| Mar 31, 2021 | 105.28% |